Sagimet Biosciences Inc (SGMT)
4.79
+0.05
(+1.05%)
USD |
NASDAQ |
May 21, 16:00
4.70
-0.09
(-1.88%)
After-Hours: 20:00
Sagimet Biosciences Price: 4.79 for May 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 21, 2024 | 4.69 | 4.83 | 4.44 | 4.79 | 738833.0 |
May 20, 2024 | 4.62 | 5.03 | 4.54 | 4.74 | 814629.0 |
May 17, 2024 | 4.71 | 4.76 | 4.54 | 4.62 | 273303.0 |
May 16, 2024 | 4.68 | 4.95 | 4.68 | 4.75 | 308829.0 |
May 15, 2024 | 4.41 | 4.84 | 4.41 | 4.62 | 409883.0 |
May 14, 2024 | 4.40 | 4.56 | 4.305 | 4.38 | 325611.0 |
May 13, 2024 | 4.56 | 4.59 | 4.24 | 4.24 | 338761.0 |
May 10, 2024 | 4.60 | 4.728 | 4.36 | 4.44 | 374056.0 |
May 09, 2024 | 4.44 | 4.595 | 4.33 | 4.57 | 396172.0 |
May 08, 2024 | 4.23 | 4.44 | 4.04 | 4.44 | 312845.0 |
May 07, 2024 | 4.27 | 4.40 | 4.163 | 4.33 | 288054.0 |
May 06, 2024 | 4.38 | 4.56 | 4.16 | 4.28 | 559222.0 |
May 03, 2024 | 4.62 | 4.76 | 4.25 | 4.32 | 770647.0 |
May 02, 2024 | 4.42 | 4.95 | 4.25 | 4.45 | 1.128M |
May 01, 2024 | 3.94 | 4.28 | 3.94 | 4.11 | 308959.0 |
Apr 30, 2024 | 4.22 | 4.22 | 3.90 | 3.90 | 599654.0 |
Apr 29, 2024 | 4.10 | 4.29 | 4.05 | 4.23 | 475474.0 |
Apr 26, 2024 | 4.00 | 4.15 | 3.88 | 4.06 | 325272.0 |
Apr 25, 2024 | 4.01 | 4.08 | 3.91 | 3.92 | 227423.0 |
Apr 24, 2024 | 4.19 | 4.270 | 4.02 | 4.17 | 219207.0 |
Apr 23, 2024 | 4.01 | 4.31 | 4.01 | 4.28 | 360993.0 |
Apr 22, 2024 | 4.18 | 4.18 | 3.96 | 4.03 | 304061.0 |
Apr 19, 2024 | 3.91 | 4.07 | 3.83 | 4.01 | 430106.0 |
Apr 18, 2024 | 4.10 | 4.17 | 3.93 | 3.97 | 337399.0 |
Apr 17, 2024 | 4.20 | 4.36 | 4.05 | 4.07 | 316023.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.23
Minimum
Nov 13 2023
18.42
Maximum
Jan 22 2024
7.576
Average
5.82
Median
Price Benchmarks
Madrigal Pharmaceuticals Inc | 242.49 |
Viking Therapeutics Inc | 64.23 |
89bio Inc | 8.95 |
Arrowhead Pharmaceuticals Inc | 25.02 |
Akero Therapeutics Inc | 20.24 |
Price Related Metrics
Price to Book Value | 0.8045 |
Earnings Yield | -25.93% |
Market Cap | 152.87M |